Climate Change Data

Recordati Industria Chimica e Farmaceutica S.p.A.

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

Scope 1 Emissions:37,768 tCO2e/year
Scope 2 Emissions:10,002 tCO2e/year (Location-based), 2,270 tCO2e/year (Market-based)
Renewable Energy Share:84% of total energy use
Total Energy Consumption:621 GJ/year
Water Consumption:2,550 Ml/year
Waste Generated:6,045.3 tons/year

ESG Focus Areas

  • People
  • Planet

Environmental Achievements

  • Approximately 84% of electricity purchased from renewable sources for the Group's plants and annexed offices
  • Solar panels installed at the production plants in Ireland and Spain
  • Approximately 7,500 trees planted in 2021 and 2022

Social Achievements

  • Launched a Diversity & Inclusion survey involving approximately 300 Group managers resulting in actionable practices to promote equal opportunities
  • Supported approximately 900 patients affected by rare diseases through assistance programs
  • 96% of employees hired on permanent contracts
  • 54% women hired in 2022 out of total new hires

Governance Achievements

  • Upgrade to “Robust” score in the overall ESG Assessment provided by Moody’s ESG Solutions
  • Rating upgrade from “Gold” to “Platinum” by EcoVadis
  • Inclusion in the FTSE4Good Index Series and in the MIB ESG Index reconfirmed
  • A rating by MSCI ESG Research

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Finalization of feasibility studies for installing additional renewable energy production systems at various plants by 2023
  • Performance of 160 ESG assessments on suppliers by 2024
Short-term Goals:
  • 100% renewable electricity purchased for production and packaging sites and annexed offices by 2025
  • Complete replacement of traditional lighting systems with LED lights in Milan plant by 2023

Environmental Challenges

  • Supply chain crisis
  • Geopolitical challenges (Ukraine conflict, Türkiye earthquake)
  • Climate change
Mitigation Strategies
  • Provided financial and logistical assistance to employees and their families in Ukraine and Türkiye
  • Provided continuity of supply of medicines
  • Implemented energy efficiency projects and promoted renewable energy sources
  • ESG monitoring plan for business partners
  • Donations to support emergency relief efforts

Supply Chain Management

Supplier Audits: 50 desk audits by EcoVadis in 2022; 178 audits by Pharmaceutical Division; 6 audits by Chemical-Pharmaceutical Division

Responsible Procurement
  • Code of Ethics
  • Supplier sustainability requirements
  • ESG monitoring

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
Transition Risks
  • Regulatory changes related to decarbonization
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: GRI

Certifications: ISO 14001 (Campoverde, Tunisia), ISO 45001 (Tunisia)

UN Sustainable Development Goals

  • Not disclosed

Contributes to 10 of the 17 UN SDGs

Sustainable Products & Innovation

  • New packaging made with 50% recycled plastic (planned for 2023)

Awards & Recognition

  • Best Social Responsibility Company (Jaba Recordati, Portugal)
  • Well Seen Company (Recordati Polska, Poland)
  • Top 100 Award 2022 (Recordati Pharma, Germany)